Total Valuation
AegirBio AB has a market cap or net worth of €6.96M. The enterprise value is €380.03.
Market Cap€6.96M
Enterprise Value€380.03
Share Statistics
AegirBio AB has 1,482,451,200 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding1,482,451,200
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
AegirBio AB’s return on equity (ROE) is -0.21 and return on invested capital (ROIC) is -23.04%.
Return on Equity (ROE)-0.21
Return on Assets (ROA)-0.14
Return on Invested Capital (ROIC)-23.04%
Return on Capital Employed (ROCE)-0.26
Revenue Per Employee814.29K
Profits Per Employee-354.09K
Employee Count251
Asset Turnover0.33
Inventory Turnover6.54
Valuation Ratios
The current PE Ratio of AegirBio AB is ―. AegirBio AB’s PEG ratio is 0.02.
PE Ratio―
PS Ratio0.00073
PB Ratio<0.01
Price to Fair Value<0.01
Price to FCF>-0.01
Price to Operating Cash Flow2.70
PEG Ratio0.02
Income Statement
In the last 12 months, AegirBio AB had revenue of 204.39M and earned -88.88M in profits. Earnings per share was -0.41.
Revenue204.39M
Gross Profit75.16M
Operating Income-129.21M
Pretax Income-90.00M
Net Income-88.88M
EBITDA-104.63M
Earnings Per Share (EPS)-0.41
Cash Flow
In the last 12 months, operating cash flow was 17.59M and capital expenditures -24.43M, giving a free cash flow of -6.84M billion.
Operating Cash Flow17.59M
Free Cash Flow-6.84M
Free Cash Flow per Share>-0.01
Dividends & Yields
AegirBio AB pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta7.75
52-Week Price Change-98.11%
50-Day Moving Average0.02
200-Day Moving Average―
Relative Strength Index (RSI)55.18
Average Volume (3m)0.00
Important Dates
AegirBio AB upcoming earnings date is Nov 5, 2026, TBA (Confirmed).
Last Earnings DateAug 20, 2026
Next Earnings DateNov 5, 2026
Ex-Dividend Date―
Financial Position
AegirBio AB as a current ratio of 0.75, with Debt / Equity ratio of 51.97%
Current Ratio0.75
Quick Ratio0.59
Debt to Market Cap655.38
Net Debt to EBITDA-0.80
Interest Coverage Ratio-7.73
Taxes
In the past 12 months, AegirBio AB has paid -1.12M in taxes.
Income Tax-1.12M
Effective Tax Rate0.01
Enterprise Valuation
AegirBio AB EV to EBITDA ratio is -0.80, with an EV/FCF ratio of -4.07.
EV to Sales0.41
EV to EBITDA-0.80
EV to Free Cash Flow-4.07
EV to Operating Cash Flow-6.67
Balance Sheet
AegirBio AB has €19.51M in cash and marketable securities with €240.41M in debt, giving a net cash position of -€220.90M billion.
Cash & Marketable Securities€19.51M
Total Debt€240.41M
Net Cash-€220.90M
Net Cash Per Share-€0.15
Tangible Book Value Per Share-€313.18
Margins
Gross margin is 34.47%, with operating margin of -63.22%, and net profit margin of -43.48%.
Gross Margin34.47%
Operating Margin-63.22%
Pretax Margin-44.03%
Net Profit Margin-43.48%
EBITDA Margin-51.19%
EBIT Margin-63.22%
Analyst Forecast
The average price target for AegirBio AB is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast―